Trial intelligence / Profile preview

Effect of methylphenidate (Rilatine/Ritalin) on severity of developmental stuttering in adults

2015-005146-55Phase 2Completed

Sponsor
Vrije Universiteit Brussel
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of methylphenidate in childhood-onset fluency disorder (COFD), sponsored by Vrije Universiteit Brussel. Primary endpoint: Objective stuttering severity metrics. Started Dec 2015; status: completed.

02

Drugs

methylphenidate
03

Conditions

childhood-onset fluency disorder (COFD)

Beyond the preview

Go deeper on 2015-005146-55.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005146-55.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call